Xenon Pharmaceuticals Inc. Phase 3 X-TOLE2 topline data for azetukalner in FOS expected March 2026 followed by anticipated NDA submission in H2 2026. Five additional Phase 3 azetu ...
Epilepsy is one of the most common neurological disorders in the world. According to the World Health Organization, around 50 ...
Epilepsy clinicians who also specialize in women’s health and work with women during the perinatal period can consult with a ...
New study suggests that an experimental peptide developed at the Hebrew University may reduce recurring seizures and support ...
Two minutes. That's how long two-year-old Briar Curtis's heart stopped during a severe seizure in April 2025. Since birth and before, Briar had been sick. Her heart rate in the womb was high and ...
Epilepsy is a complex neurological disorder characterized by spontaneous recurrent seizures, affecting approximately 50 ...
EEG acts as a window into the brain for doctors to provide diagnosis and treatment.
Epilepsy is one of the most common chronic neurological conditions encountered in small animal practice. Despite its ...
New research published in Basic & Clinical Pharmacology & Toxicology by scientists at the University of Toronto found that the non-psychoactive cannabinoids cannabidiol (CBD) and cannabigerol (CBG) ...